Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Besse

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Cancers|April 3, 2021
Efficacy of Targeted Radionuclide Therapy Using [<sup>131</sup>I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant MelanomaHussein Akil, Mercedes Quintana, Jérémy H Raymond, et al.
Investigational New Drugs|April 19, 2011
Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studiesCaroline Peyrode, Valérie Weber, Emmanuelle David, et al.
Cancer Chemotherapy and Pharmacology|July 15, 2017
Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcomaImen Miladi, Magali Vivier, Marie-Mélanie Dauplat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2012
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracerLatifa Rbah-Vidal, Aurélien Vidal, Sophie Besse, et al.
Journal of Medicinal Chemistry|September 19, 2013
Synthesis, radiofluorination, and in vivo evaluation of novel fluorinated and iodinated radiotracers for PET imaging and targeted radionuclide therapy of melanomaEmilie M F Billaud, Latifa Rbah-Vidal, Aurélien Vidal, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the <sup>64</sup>Cu-Labelling of ImmunoconjugatesAurélie Maisonial-Besset, Tiffany Witkowski, Mercedes Quintana, et al.
Experimental Dermatology|September 3, 2025
Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma ModelMarine Delmas, Benjamin Chaussin, Nathan Harismendy, et al.
Oncotarget|February 18, 2016
Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapyClaire Viallard, Jean-Michel Chezal, Florence Mishellany, et al.
European Journal of Dermatology : EJD|December 31, 2014
[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma modelsClaire Viallard, Yann Perrot, Zied Boudhraa, et al.
EJNMMI Research|September 26, 2025
Tumor sink effect on melanin-ligand [<sup>131</sup>I]ICF01012 in melanoma and its implications for targeted radionuclide therapyElodie Jouberton, Sophie Besse, Tommy Billoux, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cancers|April 3, 2021
Efficacy of Targeted Radionuclide Therapy Using [<sup>131</sup>I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant MelanomaHussein Akil, Mercedes Quintana, Jérémy H Raymond, et al.
Investigational New Drugs|April 19, 2011
Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studiesCaroline Peyrode, Valérie Weber, Emmanuelle David, et al.
Cancer Chemotherapy and Pharmacology|July 15, 2017
Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcomaImen Miladi, Magali Vivier, Marie-Mélanie Dauplat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2012
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracerLatifa Rbah-Vidal, Aurélien Vidal, Sophie Besse, et al.
Journal of Medicinal Chemistry|September 19, 2013
Synthesis, radiofluorination, and in vivo evaluation of novel fluorinated and iodinated radiotracers for PET imaging and targeted radionuclide therapy of melanomaEmilie M F Billaud, Latifa Rbah-Vidal, Aurélien Vidal, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the <sup>64</sup>Cu-Labelling of ImmunoconjugatesAurélie Maisonial-Besset, Tiffany Witkowski, Mercedes Quintana, et al.
Experimental Dermatology|September 3, 2025
Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma ModelMarine Delmas, Benjamin Chaussin, Nathan Harismendy, et al.
Oncotarget|February 18, 2016
Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapyClaire Viallard, Jean-Michel Chezal, Florence Mishellany, et al.
European Journal of Dermatology : EJD|December 31, 2014
[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma modelsClaire Viallard, Yann Perrot, Zied Boudhraa, et al.
EJNMMI Research|September 26, 2025
Tumor sink effect on melanin-ligand [<sup>131</sup>I]ICF01012 in melanoma and its implications for targeted radionuclide therapyElodie Jouberton, Sophie Besse, Tommy Billoux, et al.
Pageof 5